The expression of SULT1A1 and SULT4A1 was significantly higher in NASH patients with cirrhosis relative to such patients with steatosis; they were also significantly elevated in NASH patients with cirrhosis relative to healthy controls, patients with steatosis alone, and patients with fatty liver NASH. Here, SULT1A1 is linked to metabolic dysfunction-associated steatohepatitis.